| Literature DB >> 31284512 |
Ao Shang1, Shi-Yu Cao1, Xiao-Yu Xu1, Ren-You Gan2,3, Guo-Yi Tang1, Harold Corke4, Vuyo Mavumengwana5, Hua-Bin Li6.
Abstract
Garlic (Allium sativum L.) is a widely consumed spice in the world. Garlic contains diverse bioactive compounds, such as allicin, alliin, diallyl sulfide, diallyl disulfide, diallyl trisulfide, ajoene, and S-allyl-cysteine. Substantial studies have shown that garlic and its bioactive constituents exhibit antioxidant, anti-inflammatory, antibacterial, antifungal, immunomodulatory, cardiovascular protective, anticancer, hepatoprotective, digestive system protective, anti-diabetic, anti-obesity, neuroprotective, and renal protective properties. In this review, the main bioactive compounds and important biological functions of garlic are summarized, highlighting and discussing the relevant mechanisms of actions. Overall, garlic is an excellent natural source of bioactive sulfur-containing compounds and has promising applications in the development of functional foods or nutraceuticals for the prevention and management of certain diseases.Entities:
Keywords: anticancer; antimicrobial; antioxidant; cardiovascular protection; garlic; health benefits; organic sulfides; phytochemicals
Year: 2019 PMID: 31284512 PMCID: PMC6678835 DOI: 10.3390/foods8070246
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1The chemical structures of the main organosulfur compounds in garlic.
Figure 2The mechanisms of the antihypertensive properties of garlic extract via increasing the production of nitric oxide (NO) in vascular smooth muscle cells. The l-arginine (L-Arg) in aged garlic extract (AGE) could be transformed into NO and L-citruline (L-Cit) mediated by nitric oxide synthase (NOS). Moreover, the nitrite in the fermented garlic extract (FGE) could be converted into NO in vivo by Bacillus subtilis. NO and atrial natriuretic peptide (ANP) activated particulate guanylyl cyclase (pGC) and soluble guanylyl cyclase (sGC), thus catalyzing the transform of guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP). The elevated cGMP activated PKG, and PKG decreased intracellular Ca2+ concentration by increasing intracytoplasmic Ca2+ transport into the sarcoplasmic reticulum through the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pathway, thereby preventing the release of Ca2+ from the sarcoplasmic reticulum to the cytoplasm, and stimulating the Ca2+-activated K+ (BKCa) channel on the cell membrane, as well as reducing the Ca2+ influx. As a result, the vascular smooth muscle relaxed, and the blood vessels dilated.
Figure 3The mechanisms of garlic and its active compounds on the inhibition of the cell cycle in cancer cells. Garlic extract activated ataxia-telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2), and inhibited the phosphorylation of Cdc25C and Cdc2, which down-regulated cyclin B1 and up-regulating p21WAF1, thereby inhibiting the cell cycle in the G2/M-phase. Aged garlic extract can down-regulate Cyclin B1 and Cyclin-dependent kinase 1 (CDK1) and block the cell cycle in the G2/M-phase. Diallyl trisulfide and S-propargyl-l-cysteine can also block the cell cycle in the G2/M-phase. Moreover, S-allyl-cysteine induced cell cycle arrest in the G1/S-phase, and allicin induced cell cycle arrest during the S-phase.
The biological activities of garlic and its active components.
| Product | Compounds | Study Type | Subjects/ | Main Effects | Possible Mechanisms | Ref. |
|---|---|---|---|---|---|---|
|
| ||||||
| Aged garlic extract | In vitro | Human endothelial cells | Protecting cells against oxidative stress | Inducing the expression of several antioxidant enzymes, HO-1 and GCLM subunit, through Nrf2- ARE pathway | [ | |
| Saponins | In vitro | Mouse-derived C2C12 myoblasts | Protecting cells against the growth inhibition and DNA damage induced by H2O2 | Scavenging intracellular reactive oxygen species | [ | |
|
| ||||||
| Ethyl linoleate | In vitro | Lipopolysaccharide-stimulated RAW 264.7 macrophages | Reducing the production of NO and prostaglandin E-2 | Down regulating the expression of iNOS and COX2 | [ | |
| Garlic 14-kDa protein | In vitro | Lipopolysaccharide-stimulated J774A.1 macrophages | Inhibiting the inflammatory mediators such as NO, TNF-α, and IL-1β | Inhibiting the transcription factor NF-κB signaling pathway | [ | |
| Aged garlic extract | In vivo | Apolipoprotein E-knockout mice | Inhibiting inflammation | Reducing the level of TNF-α and interleukin IL-1 receptor-associated kinase 4 | [ | |
| Allicin | In vivo | BALB/c mice | Protecting against the inflammatory response induced by schistosome infection | [ | ||
| Garlic tablets (equal to 2.5 g fresh garlic daily) | Clinical trial | 40 post-menopausal obese or overweight patients | Alleviating osteoarthritis | Reducing resistin | [ | |
|
| ||||||
| Garlic “Rosato” and “Caposele” | In vitro | Inhibiting the growth of bacteria | [ | |||
| Aged garlic extract | Allicin | In vitro |
| Inhibiting the growth of bacteria | [ | |
| Garlic oil | In vitro | Inhibiting the growth of bacteria | [ | |||
| In vitro |
| Inhibiting the growth of bacteria | Penetrating into cells and organelles | [ | ||
| In vitro |
| Disrupting the normal metabolism of bacteria | Inducing key genes involved in oxidative phosphorylation, the cell cycle, and protein processing in the endoplasmic reticulum | [ | ||
| Raw garlic | Clinical trial | 15 patients with | Inhibiting | [ | ||
|
| ||||||
| Fresh garlic | Polysaccharides/ | In vitro | RAW 264.7 macrophages | Exerting immunomodulatory effect | Regulating the expressions of IL-6, IL-10, TNF-α, and interferon-γ | [ |
| Garlic oil | In vivo | Wistar rats | Normalizing several immunological parameters of rats, such as the serum total immunoglobulin concentration and T-cell subtype CD4+ | [ | ||
| Selenizing garlic polysaccharides | In vivo | 14-day-old chickens | Promoting lymphocyte proliferation | [ | ||
| Aged garlic extract | Clinical trial | 56 healthy human participants | Reducing the occurrence and severity of cold and flu | [ | ||
|
| ||||||
| Aged garlic extract | In vitro | Isolated rat aortic rings | Leading to endothelial-dependent vasodilation | Stimulating the production of NO | [ | |
| Aged black garlic extract | Polyphenols | In vivo | Isolated hearts of male Sprague–Dawley rats | Relaxing coronary arteries before and after ischemia-reperfusion in rat | [ | |
| Aged garlic extract | S-1-propylenecysteine | In vivo | Spontaneous hypertension rats | Improving peripheral blood circulation | [ | |
| Fermented garlic extract by | In vivo | Spontaneous hypertension rats | Reducing the systolic blood pressure | Modulating the sGC-cGMP-PKG pathway | [ | |
| Fermented garlic extract | In vivo | Monocrotaline-induced pulmonary hypertension rats | Alleviating pulmonary hypertension | Decreasing the expression of vascular endothelial cell adhesion molecule-1 and MMP- | [ | |
| Garlic | Alliin | In vivo | Female Wistar albino rats | Increasing the activity of captopril on inhibiting ACE and hypertension | [ | |
| 1.5% black garlic extract | In vivo | High-fat diet-fed male Sprague–Dawley rats | Modulating the metabolism of lipid and cholesterol | Reducing the mRNA expression of sterol regulatory element binding protein-1c | [ | |
| Raw garlic | Allyl methyl sulfide/Allyl methyl sulfoxide | In vivo | Male Sprague–Dawley rats | Reduce cardiac hypertrophy remodeling induced by isoproterenol | Increasing Na+/K+-ATPase protein level | [ |
| Raw garlic | In vivo | Streptomycin-induced diabetic rats | Protecting the heart function | Deacetylating manganese superoxide dismutase | [ | |
| Garlic extract | In vivo | Insulin-resistant obese rats | Protecting heart rate variability, cardiac dysfunction, and mitochondrial dysfunction | [ | ||
| In vivo | Rat model of gentamicin-induced chronic renal failure | Protecting the heart tissue | Reducing oxidative stress | [ | ||
| Aged garlic extract | SAC | In vivo | Rats with myocardial dysfunction induced by isoproterenol | Protecting against cardiotoxicity | [ | |
| Aged garlic extract | In vivo | Apolipoprotein E-knockout mice | Inhibiting inflammatory response to prevent atherosclerosis | Reducing serum level of C-reactive protein and thromboxane B-2, protein level of TNF-α and IL-1 receptor-associated kinase 4 | [ | |
| In vivo | Apolipoprotein E-knockout mice | Inhibiting the vascular inflammation and lipid deposition in the early stage of atherosclerosis development | [ | |||
| High temperature and high pressure-processed garlic | In vivo | High-cholesterol diet-fed Sprague–Dawley rats | Reducing the levels of total cholesterol, low-density lipoprotein cholesterol and triglyceride | [ | ||
| Garlic | Cohort study | 30 patients with diabetic dyslipidemia | Decreasing the level of cholesterol and low-density lipoprotein | [ | ||
| Aged garlic | Clinical trial | 41 patients with hypercholesterolemia | Reducing the activity of myeloperoxidase and lipid hydroperoxide in serum Decreasing the concentration of F2-isoprostanes in plasma and urine | [ | ||
| Enzymatic browning processed garlic | Clinical trial | 44 patients with hypertension | Reducing systolic blood pressure and diastolic blood pressure | [ | ||
|
| ||||||
| Garlic extract | In vitro | Bladder cancer EJ cells | Inducing G2/M-phase cell cycle arrest | Activating the ATM pathway and CHK2; | [ | |
| Aged garlic extract | In vitro | Colorectal cancer cell lines (SW480 and SW620) | Decreasing invasive activity | Inhibiting cell motility | [ | |
| In vitro | DLD-1 human colon cancer cells (ATCC CCL-221) | Inhibiting cell proliferation | Down regulating the expression of cyclin B1 and CDK1 | [ | ||
| Crude garlic extract | Lipid bioactive compounds | In vitro | Human liver cancer (Hep-G2) | Inhibiting the growth rate of Hep-G2, PC-3, MCF-7, and TIB-71 cells by 80%–90% at 72 h (P < 0.05). | Inhibiting cell proliferation | [ |
| Allicin | In vitro | Human gastric adenocarcinoma cell line | Inhibiting cell proliferation | Inducing cell cycle arrest at S-phase | [ | |
| DATS | In vitro | Human gastric carcinoma cell line (SGC-7901) | Inhibiting cell proliferation | Accumulating Bax, p53, and cytochrome C and decreasing the expression of Bcl-2 | [ | |
| In vitro | Human breast cancer cell line (MDA-MB-231) | Inhibiting angiogenesis | [ | |||
| Z-ajoene | In vitro | Glioblastoma multiforme cells | Inhibiting the growth of the cancer stem cells population | [ | ||
| In vitro | Human breast cancer cells (MDA-MB-231) | Inhibiting cell growth | Targeting the folding of proteins in the endoplasmic reticulum of cancer cells | [ | ||
| SAC | In vitro | Human epithelial ovarian cancer cell line (A2780) | Inhibiting cell proliferation | Decreasing the expression of pro-caspase-3, Parp-1 Bcl-2 and increasing active caspase-3 and Bax | [ | |
| SPRC | In vitro | Human pancreatic ductal adenocarcinoma cells (Panc-1) | Inhibiting cell proliferation | Inducing G2/M-phase cell cycle arrest | [ | |
| SAMC | In vitro | Human colorectal carcinoma cell line (SW620) | Inhibiting cell proliferation | Regulating JNK and p38 MAPK pathways | [ | |
| In vitro | Hepatoma cell lines (Hep3B and Huh-7) | Reducing the cell viability | [ | |||
| Alliin | In vitro | Gastric adenocarcinoma cells | Regulating cell apoptosis | Generating reactive oxygen species | [ | |
| Aged garlic extract | In vivo | Adult male Wister albino rats treated with cisplatin | Improving the renal histological, ultrastructural and biochemical changes, such as hemorrhage, glomerular atrophy, tubular necrosis and degeneration | [ | ||
| In vivo | Fibrosarcoma tumors implanted BALB/c mice | Improving the immune responses of mice to fibrosarcoma | Increasing the ratio of CD4+/CD8+ | [ | ||
| Garlic and lemon aqueous extract | In vivo | BALB/c mice xenograft model of breast cancer EMT6/P cells | Reducing tumor size | Inhibiting the expression of vascular endothelial growth factor | [ | |
| Allicin | In vivo | Female Swiss albino mice | Alleviating liver injury induced by tamoxifen | Changing the decrease of superoxide dismutase, glutathione and total protein and the increase of aspartate aminotransferase, alkaline phosphatase and alanine aminotransferase levels | [ | |
| DADS | In vivo | FVB/N mice | Preventing colorectal tumorigenesis induced by azoxymethane and dextran sulfate | Inhibiting inflammation | [ | |
| DATS | In vivo | Female BALB/c-nude mouse xenograft model of human gastric carcinoma SGC-7901 cells | Inhibiting tumor growth | Regulating the expressions of MMP-9 and E-cadherin protein | [ | |
| SPRC | In vivo | Xenograft model of pancreatic ductal adenocarcinoma Panc-1 cells | Inhibiting tumor growth | Regulating the level of JNK protein | [ | |
| SAMC | In vivo | Mouse xenograft model of hepatoma Huh-7 cells | Inhibiting tumor growth | Interacting with the Wnt-pathway co-receptor LRP6 on the cell membrane | [ | |
| Raw, crushed garlic | Cohort study | 17 volunteers from Beltsville, Maryland | Up-regulating seven genes including | [ | ||
| Garlic extract | Cohort study | Patients who received chemotherapy for hematological malignancies | Protective effect on febrile neutropenia in lower-risk subgroup | [ | ||
|
| ||||||
| Black garlic extract | In vitro | Rat clone-9 hepatocytes | Inhibiting apoptosis, lipid peroxidation, oxidative stress, and inflammation | [ | ||
| Garlic extract | In vivo | Wistar rats | Attenuating the liver damage induced by alloxan | [ | ||
| Single clove garlic extract | In vivo | Male rabbits | Protecting against CCl4-induced acute liver injury | [ | ||
| LAFGE | In vivo | C57/BL6 J mice | Reducing the liver lipid level | [ | ||
| In vivo | rats | Inhibiting liver cell apoptosis | Suppressing MAPK phosphorylation | [ | ||
| Garlic oil | In vivo | 1,3-Dichloro-2-propanol-treated rats | Protecting liver | Enhancing the activities of hepatic antioxidant enzymes | [ | |
| DADS | In vivo | Wistar rats | Protecting mice from nonalcoholic fatty liver disease induced by long-term high-fat diet. | Reducing the release of pro-inflammatory cytokines in the liver | [ | |
| LAFGE | Clinical trial | 36 adults with mildly high level of serum gamamyl glutamyl transpeptiase | Improving the levels of gamamyl glutamyl transpeptias and alanine aminotransferase without adverse effects | [ | ||
|
| ||||||
| Black garlic extract | In vitro | Small intestine | Stimulating gastrointestinal peristalsis | [ | ||
| DADS | In vitro | Interferon-γ-stimulated intestinal cells | Reducing interferon-inducible protein-10, IL-6 | [ | ||
| In vivo | Male ICR mice | Improving the colitis induced by dinitrobenzenesulfonic acid | [ | |||
| Garlic and cabbage extract | In vivo | Sprague–Dawley rats | Reducing the length of gastric ulcer, the total gastric acid, gastric juice volume, total bacteria count, and histopathological changes caused by aspirin | [ | ||
| Aged garlic extract | In vivo | Male albino rats | Healing the gastric mucosal injury induced by indomethacin | [ | ||
| In vivo | Male Wistar rats | Preventing the indomethacin-induced ulcer | Reducing oxidative stress | [ | ||
| Allicin | In vivo | Dextran sulfate sodium-induced colitis mice | Alleviating the ulcerative colitis induced by dextran sulfate sodium | Inhibiting the activation of AP-1/NF-κB/signal transducer and activator of transcription-1 Inhibiting the phosphorylation of p38, JNK, and extracellular signal-regulated kinase 1/2 -regulated PPAR-γ | [ | |
| Raw garlic | Clinical trial | 15 patients with | Decreasing the bacterial urease activity Reducing the residing of | [ | ||
|
| ||||||
| Garlic | In vivo | Diabetic rats | Protecting against diabetic retinopathy Improving weight, blood glucose, and morphological changes of retinal tissue | [ | ||
| Clinical trial | 768 patients with type 2 diabetes mellitus | Reducing fructosamine and glycosylated hemoglobin | [ | |||
|
| ||||||
| LAFGE | In vivo | High-fat diet-fed male C57BL/6J mice | Reducing the weight | Inhibiting the lipogenesis by down-regulating the mRNA and protein expression of PPAR-γ, C/EBPα, and lipogenic proteins | [ | |
| Methanolic extract of black garlic | In vivo | High-fat diet-fed male Wistar rats | Reducing the weight | Upregulating the expression of AMPK, forkhead box protein O1, perilipin, and adiponectin in the adipose tissue | [ | |
| Garlic oil | In vivo | High-fat diet-fed male Sprague–Dawley rats | Counteracting the influence of high-fat diet on the body weight and adipose tissue weight | [ | ||
|
| ||||||
| Aged garlic extract | FruArg | In vitro | Lipopolysaccharide-activated murine BV-2 microglial cells | Alleviating neuroinflammation | Inhibiting the production of NO | [ |
| Garlic extract | In vivo | Female Wistar rats | Reducing the concentration of Pb in the blood and brain | [ | ||
| Aged garlic extract | In vivo | Adult male Wistar rats | Attenuating the damage of working memory | Improving the loss of cholinergic neurons | [ | |
| Ethanol extract of garlic | In vivo | Diabetic Wistar rats | Improving memory | Increasing the activity of Na+/K+ ATPase, Ca2+ ATPase, and glutamine synthetase in the hippocampus | [ | |
| Z-ajoene | In vivo | Male gerbils | Preventing I/R-induced delayed neuronal death and gliosis | Reducing lipid peroxidation in the CA1 | [ | |
| SAC | In vivo | Male albino Wistar rats | Ameliorating the cognitive impairment | Reducing oxidative stress, neuroinflammation, astrogliosis, and acetylcholinesterase activity | [ | |
|
| ||||||
| Aqueous extract of garlic | In vivo | Type 1 diabetic rats | Reducing the oxidative stress in the kidneys | [ | ||
| In vivo | Wistar rats | Improving the renal plasma biochemical factors induced by alloxan | [ | |||
| DATS | In vivo | Male albino rats | Protecting the kidney from oxidative stress injury induced by As | Activating the Nrf2-ARE pathway | [ | |
Abbreviations: ACE, angiotensin-converting enzyme; AHR, aryl hydrocarbon receptor; allicin, diallyl thiosulfonate; alliin, S-allyl-cysteine sulfoxide; AMPK, adenosine monophosphate-activated protein kinase; AP-1, activator protein 1; ARE, antioxidant response element; ARNT, aryl hydrocarbon receptor nuclear translocator; ATM, ataxia-telangiectasia mutated; Bax, Bcl-2 associated X; Bcl-2, B cell lymphoma-2; CDK1, cyclin-dependent kinase 1; cGMP, cyclic guanosine monophosphate; CHK2, checkpoint kinase 2; COX2, cyclooxygenase-2; DADS, diallyl disulfide; DAS, diallyl sulfide; DATS, diallyl trisulfide; eNOS, endothelial nitric oxide synthase; FruArg, N-α-(1-deoxy-D-fructos-1-yl)-l-arginine; GCLM, glutamate-cysteine ligase modifier; HIF1A, hypoxia-inducible factor 1α; HO-1, heme oxygenase-1; IL, interleukin; iNOS, inducible NO synthase; JNK, Jun N-terminal kinase; JUN, proto-oncogene c-Jun; LAFGE, fermented garlic extract by Lactobacillus plantarum BL2; MMP-9, matrix metalloproteinase-9; NFAM1, nuclear factor of activated T cells (NFAT) activating protein with immunoreceptor tyrosine-based activation motif 1; NF-κB, nuclear factor-kappa B; NO, nitric oxide; Nrf2, nuclear factor erythrobia-2 related factor 2; OSM, oncostatin M; Parp-1, poly (ADP-ribose) polymerase-1; PKG, protein kinases G; PPAR-γ, peroxisome proliferator-activated receptor-γ; p38 MAPK, p38 mitogen activated protein kinase; REL, V-relavian reticuloendotheliosis viral oncogene homolog; SAC, S-allyl-cysteine; sGC, soluble guanylyl cyclase; SAMC, S-allylmercaptocysteine; SPRC, S-propargyl-l-cysteine; STAT-1, signal transducer and activator of transcription-1; TNF-α, tumor necrosis factor-α; Wnt5a, wingless-type MMTV integration site family member 5A.